TY - JOUR JF - QHMS JO - Intern Med Today VL - 25 IS - 3 PY - 2019 Y1 - 2019/7/01 TI - The Effect of Discontinuation of Angiotensin-II Receptor Blocker on Therapeutic Effect of Synthetic Erythropoietin on Anemia Modification in Hemodialysis Patients TT - بررسی تأثیر حذف مسدودکننده گیرنده آنژیوتانسین-۲ در پاسخ به درمان با اریتروپویتین صناعی در کم‌خونی‌های بیماران تحت همودیالیز N2 - Aims The aim of this study was to evaluate the effect of discontinuation of losartan in response to synthetic erythropoietin therapy on hemoglobin level in patients on maintenance hemodialysis. Methods & Materials This study was a pre-and post-interventional clinical trial. The population of the study was hemodialysis patients with chronic renal failure. In the beginning of the study, and three months after removal of losartan, the patients’ hemoglobin changes were compared. Findings Hemoglobin was significantly increased at the end of the study in all patients (from 10.90±1.66 at the beginning of the study to 11.37±1.42g/dl at the end of 3 months, P=0.046). No significant changes were seen in the hemoglobin level before and after intervention between patients according age, sex, and duration of the disease. Conclusion There was a significant increase in hemoglobin level at the end of study after losartan discontinuation. But this increase did not have a significant relationship with patient’s age, sex as well as the duration of the disease. SP - 230 EP - 243 AU - Ejlali, Farid Reza AU - Khazaei, Mahmood Reza AU - Mostafavian, Zahra AU - Moshari, Jalil AD - Department of Pediatrics, Faculty of Medicine Sciences, Mashhad Branch, Islamic azad University, Mashhad, Iran. KW - End-stage renal disease UR - http://imtj.gmu.ac.ir/article-1-3179-en.html DO - 10.32598/hms.25.3.230 ER -